AU2002366713A1 - Nucleotide polymorphisms associated with osteoarthritis - Google Patents

Nucleotide polymorphisms associated with osteoarthritis

Info

Publication number
AU2002366713A1
AU2002366713A1 AU2002366713A AU2002366713A AU2002366713A1 AU 2002366713 A1 AU2002366713 A1 AU 2002366713A1 AU 2002366713 A AU2002366713 A AU 2002366713A AU 2002366713 A AU2002366713 A AU 2002366713A AU 2002366713 A1 AU2002366713 A1 AU 2002366713A1
Authority
AU
Australia
Prior art keywords
osteoarthritis
nucleotide polymorphisms
polymorphisms associated
nucleotide
polymorphisms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002366713A
Other versions
AU2002366713A8 (en
Inventor
Karen Anne Jones
Alan Schafer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of AU2002366713A1 publication Critical patent/AU2002366713A1/en
Publication of AU2002366713A8 publication Critical patent/AU2002366713A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2002366713A 2001-12-20 2002-12-19 Nucleotide polymorphisms associated with osteoarthritis Abandoned AU2002366713A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34260301P 2001-12-20 2001-12-20
US60/342,603 2001-12-20
PCT/US2002/041225 WO2003054166A2 (en) 2001-12-20 2002-12-19 Nucleotide polymorphisms associated with osteoarthritis

Publications (2)

Publication Number Publication Date
AU2002366713A1 true AU2002366713A1 (en) 2003-07-09
AU2002366713A8 AU2002366713A8 (en) 2003-07-09

Family

ID=23342513

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002366713A Abandoned AU2002366713A1 (en) 2001-12-20 2002-12-19 Nucleotide polymorphisms associated with osteoarthritis

Country Status (2)

Country Link
AU (1) AU2002366713A1 (en)
WO (1) WO2003054166A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003023007A2 (en) 2001-09-07 2003-03-20 Bristol-Myers Squibb Company Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy39
WO2004097044A1 (en) * 2003-04-29 2004-11-11 Oxagen Limited Method of diagnosins a genetic susceptibility for bone damage
CA2561669A1 (en) * 2004-04-01 2005-10-20 Sequenom, Inc. Methods for identifying risk of osteoarthritis and treatments thereof
GB0425197D0 (en) * 2004-11-15 2004-12-15 Ares Trading Sa Leucine-rich repeat (LRR) motif containing proteins
WO2007028212A1 (en) * 2005-09-08 2007-03-15 Apollo Life Sciences Limited Noggin and chimeric molecules thereof
FR2908654B1 (en) * 2006-11-20 2014-04-04 Oreal COSMETIC USE OF CHITINASE PROTEINS
CA2690685A1 (en) * 2007-06-20 2008-12-24 Galapagos N.V. Molecular targets and compounds, and methods to identify the same, useful in the treatment of bone and joint degenerative diseases
WO2009092381A1 (en) 2008-01-23 2009-07-30 Herlev Hospital, Region Hovedstaden Ykl-40 as a general marker for non-specific disease
NZ592241A (en) 2008-09-15 2012-11-30 Herlev Hospital Ykl-40 as a marker for gastrointestinal cancers
US9944985B2 (en) 2011-11-30 2018-04-17 Children's Hospital Medical Center Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support
EP3019619B1 (en) 2013-07-11 2021-08-25 ModernaTX, Inc. Compositions comprising synthetic polynucleotides encoding crispr related proteins and synthetic sgrnas and methods of use
CN106460042A (en) 2014-02-24 2017-02-22 儿童医院医学中心 Methods and compositions for personalized pain management
US11618924B2 (en) 2017-01-20 2023-04-04 Children's Hospital Medical Center Methods and compositions relating to OPRM1 DNA methylation for personalized pain management
CN111088369B (en) * 2020-01-17 2022-11-15 天津奥群牧业有限公司 Detection method, primer pair and application of sheep RORA gene insertion/deletion polymorphism

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265157B1 (en) * 1991-12-03 2001-07-24 Allegheny University Of The Health Sciences Compositions and methods for detecting altered COL1A1 gene sequences

Also Published As

Publication number Publication date
AU2002366713A8 (en) 2003-07-09
WO2003054166A2 (en) 2003-07-03
WO2003054166A3 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
AU2002351077A1 (en) Oligonucleotides modified with novel alpha-l-rna analogues
AU2001272482A1 (en) Osteolevin gene polymorphisms
AU2002366713A1 (en) Nucleotide polymorphisms associated with osteoarthritis
AU2001245489A1 (en) Human single nucleotide polymorphisms
AU2001285693A1 (en) Bio-reactor
AU2002319233A1 (en) Interferon alpha-14 polymorphism
AU2002211373A1 (en) Haplotypes of the por gene
AU2258601A (en) Ibd-related polymorphisms
WO2003014319A9 (en) Polymorphisms associated with multiple sclerosis
AU2002366709A1 (en) Nucleotide polymorphisms associated with osteoporosis
AU1773501A (en) Human single nucleotide polymorphisms
AU2002360349A1 (en) Single nucleotide polymorphisms in gh-1
AU2002307963A1 (en) Genetic typing
AU2002216946A1 (en) Modified pna molecules
AU2002364894A1 (en) Single nucleotide polymorphisms and mutations on alpha-2-macroglobulin
GB0229139D0 (en) Gene polymorphisms
AU2002214446A1 (en) Single nucleotide polymorphisms
AUPR282501A0 (en) Expression facilitating nucleotides
AU2001253091A1 (en) Haplotypes of the gp1ba gene
AU2003241762A1 (en) Dna shuflling
AU2002334632A1 (en) Lipid-associated molecules
AU2002249793A1 (en) Human single nucleotide polymorphisms
AU2002309917A1 (en) Lipid-associated molecules
AU2001250902A1 (en) Haplotypes of the gnb3 gene
AU2002324234A1 (en) Pthr1 gene polymorphisms

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase